Basic Information
Basic information for ITGA9-AS1-230-32aa
Peptide Name ITGA9-AS1-230-32aa
Genome Position chr3:37720162-37720257[-]
Species Human
Peptide Sequence MEPCLRGQQLTNLFPRVGTSTLLLLGTSQDSS
Peptide Length 32
Unique No (ITGA9-AS1-221-32aa-1,ITGA9-AS1-231-32aa-2)
Grand Average of Hydropathicity -0.075
Relative Molecular Mass 4022.57
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000661580;ITGA9-AS1-230
Transcript Length 1739
Coding Ability 0.5101
DNA Sequence Corresponding to Peptide ATGGAGCCCTGTCTCAGGGGGCAGCAGCTTACTAATCTCTTCCCTCGGGTTGGCACATCCACTTTGCTACTCCTGGGTACATCTCAGGACTCTTCT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :